Director Douglas Roeder Buys 2,218 Shares of Senseonics, Signaling Confidence in Growing Diabetes‑Care Tech Company
Senseonics insider purchase signals confidence in its growth. Director Doug Roe‑der buys shares, suggesting undervaluation and future upside for glucose‑monitoring tech.
2 minutes to read
